Lineage Cell Therapeutics to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #AMD--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its second quarter 2020 financial and operating results on Thursday, August 6, 2020, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on Thursday, August 6, 2020, at 5:30 p.m. Eastern Time/2:30 p.m. Pac